Is Medical Properties Trust (MPT) overvalued or fairly valued?

MarketChacha shows Medical Properties Trust's valuation in context — a forward P/E of about 32.8, a price-to-book of about 0.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Medical Properties Trust's revenue?

Medical Properties Trust reported revenue of $972.0M for FY2025, with net profit of $-277.0M, per official filings.

What is the share price of Medical Properties Trust (MPT)?

Medical Properties Trust last traded at $4.81 (-1.3% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Medical Properties Trust

MPT · NYSE · Real Estate · United States

$4.81-1.3%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:28 PM

Snapshot

TickerMPT

ExchangeNYSE

SectorReal Estate

IndustryREIT - Healthcare Facilities

CountryUnited States

Employees121

HeadquartersBirmingham, United States

Market cap$2.9B

P/B0.6

Volume2.5M

Websitewww.medicalpropertiestrust.com

Filings tracked3

About Medical Properties Trust

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. was incorporated in 2003.

Profile as reported by Yahoo Finance.

Who owns it

Insiders17.5%
Institutions60.0%
Public & other22.5%

628 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.12.59%
Vanguard Portfolio Management LLC7.20%
State Street Corporation4.27%
Vanguard Capital Management LLC3.48%
Charles Schwab Investment Management, Inc.2.00%
AQR Capital Management, LLC1.85%
Geode Capital Management, LLC1.67%
Two Sigma Investments, LP1.40%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Latest ROE of -6.0% is on the low side — the business earns a modest return on shareholder capital.

Net margin trend-63.8% → -28.5%

Margin has expanded by about 35.3 points — the business is getting more profitable.

Return on equity-6.0%

Latest ROE of -6.0% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $260.3M · EPS 0.04

Next fiscal year

Rev $1.1B · EPS 0.15

Est. earnings growth +33.3%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$3.9552-wk range$6.47

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$2.9B

Day change

-1.3%

Fwd P/E

32.8

P/B

0.6

Div yield

7.39%

Beta

1.46

Revenue (FY2025)

$972.0M

Net margin

-28.5%

ROE

-6.0%

Revenue CAGR (2y)

+5.6%

EPS (FY2025)

-0.46

Net profit (FY2025)

$-277.0M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about MPT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$972.0M	$-277.0M	-0.46	-28.5%	-6.0%
FY2024	$995.5M	$-2.4B	-4.02	-242.1%	-49.9%
FY2023	$871.8M	$-556.5M	-0.93	-63.8%	-7.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$252.1M	$32.8M	0.05	13.0%
2025Q3	$237.5M	$-77.7M	-0.13	-32.7%
2025Q2	$240.4M	$-98.4M	-0.16	-40.9%
2025Q1	$223.8M	$-118.3M	-0.20	-52.8%
2024Q3	$225.8M	$-801.2M	-1.34	-354.8%
2024Q2	$266.6M	$-320.6M	-0.54	-120.3%
2024Q1	$271.3M	$-875.6M	-1.46	-322.7%
2023Q3	$306.6M	$116.7M	0.19	38.1%
2023Q2	$337.4M	$-42.0M	-0.07	-12.5%
2023Q1	$350.2M	$32.8M	0.05	9.4%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Shareholder vote results, Exhibits
SEC6/1/2026material
10-Q filing
SEC5/8/2026
8-K — Results of operations, Exhibits
SEC4/30/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.